MPM Bioventures 2018, L.P., 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 86,482 shares at $7.06 ($617K) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Open-market sale of $617k TRDA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.06 | 29,088 | $205K | 33.3% |
| 2 | $7.19 | 25,131 | $181K | 29.3% |
| 3 | $7.17 | 32,263 | $231K | 37.5% |
| Total | $7.14 avg | 86,482 | $617K | 100% |
| Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| AKTS | BUY | 2026-01-14 | $20.0M | — | Filing → |
| ITOS | SELL | 2021-12-07 | $3.3M | — | Filing → |